Conference to debate the relationship between psychiatry and the pharmaceutical industry :: Health-Informant.com

Current articles and info about your health

Friday, 05th December 2008

home about authors news books xml feed sitemap privacy contact us

There are 8 users online

add to favorites

make home page

Addiction Issues
Aging
Allergies & Sinuses
Alternative Medicine
Beauty & Health
Books & Reading
Common Illnesses
Community Service
Diabetic Health
Dieting
Diseases
Environmental Health
Exercise and Fitness
Health Education
Health Industry
Health Insurance
Health Legal Issues
Health Technology
Healthcare Services
Healthy Eating
Medical Equipment & Products
Men's Health
Mental and Emotional Health
Muscle & Back Pain
Nutrition and Supplements
Pediatrics
Pet Health
Physical Therapy & Massage
Prevention Health
Vision Health
Weight Management
Women's Health

Our Newsletter

Other Resources

For other sources of health news, tips, and information, visit our resources page

Submit an Article

Would you like to have your article posted? Click Here

Conference to debate the relationship between psychiatry and the pharmaceutical industry
Added: 12/17/2003 Type: Summary Viewed: 939 time(s) [ Not Rated Yet ]

How would you rate this article: Bad Good Go ť

Printer Friendly Version

Debate the relationship between psychiatry and the pharmaceutical industry

Consumption of prescription drugs has risen. A large majority of these drugs are for psychiatric complaints. Mental health charity Mind and the Critical Psychiatry Network are hosting a conference to examine the relationship between psychiatry and the pharmaceutical industry. Mind and the Critical Psychiatry Network are teaming up with conference organisers Pavilion to hold the event in London on Monday 17 November. Key members from both sides of the debate will address areas of concern to all those involved in working with and supporting people who experience mental distress.

The conference will address: Where would we be without pharmaceutical companies?; Ethical perspectives in psychiatry; On what evidence is prescribing in psychiatry based?; How do pharmaceutical companies exert influence in the media and public mind?

Speakers include: Professor Robert Kerwin, Psychoparmacologist, Institute of Psychiatry; Dr Mike Shooter President, Royal College of Psychiatry; Dr Joanna Moncrieff Psychiatrist and Co-chair, Critical Psychiatry Network; David Healy Psychiatrist; Dr Kamran Abbasi Deputy Editor, British Medical Journal; Peter Beresford Director, The Centre for Citizen Participation, Brunel University; Richard Brook Chief Executive, Mind; Sarah Bosley, Health Writer, The Guardian; Charles Medawar, Social Auit UK; Professor John Abrahams, Sociologist, University of Sussex; David Crepaz-Keay, Director, Mental Health Media.

Dr Joanna Moncrieff, Psychiatrist and Co-chair, Critical Psychiatry Network said:
Psychiatry is in the grip of the pharmaceutical industry. The industry is creating spurious uses for psychotropic drug treatments and overstating the benefits of drugs for established psychiatric disorders. The psychiatric profession is allowing this to happen.

Article Pages: 1

Article Comments

Add Comment |

View All (0)

There are currently no comments for this article.

Advanced Search


Good Resources
Create a Happier Life Diabetes Diet High Protein, Low Cal Food Affiliate With Us